Yahoo Web Search

Search results

1. • 

     Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?

     Zacks via Yahoo Finance· 6 days ago

     Continued supply constraints for incretin-based products like Trulicity, Mounjaro and Zepbound hurt...

2. • 

     Goldman Sachs raises Eli Lilly 2030 GLP-1 medications forecast to $130bn By Investing.com

     Investing.com· 6 days ago

     Goldman Sachs raises Eli Lilly 2030 GLP-1 medications forecast to $130bn

3. • 

     Saxenda vs. Wegovy: What to know about each

     Medical News Today· 2 days ago

     Saxenda (liraglutide) and Wegovy (semaglutide) are brand-name injections. Saxenda is used daily, while Wegovy is used weekly. This article explains the...

4. • Are weight-loss drugs the future of medicine? Here's what KC-area experts had to say

     KSHB-TV Kansas City· 5 days ago

     A new class of drugs have taken over the market: some treat type 2 diabetes, and some focus on weight loss. Semaglutide (commonly known as Ozempic or Wegovy) and Tirzepatide

5. • 

     Top Research Reports for Eli Lilly, T-Mobile & BHP

     Zacks via Yahoo Finance· 5 days ago

     Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), T-Mobile US, Inc. (TMUS) and BHP Group...

6. • 

     Metabolic syndrome a scary epidemic that few can define

     UPI· 5 days ago

     1 of 4 | Having unhealthy levels of sugar and fat in the blood, elevated cholesterol, high blood...

7. • 

     Is Taking Appetite Suppressants a Good Idea? Here's What to Know.

     Men's Health via Yahoo News· 6 days ago

     These medications are injections. Tirzepatide (Zepbound) is a GLP-1 agonist injection medication...

8. • 

     Experts warn of dangerous weight loss drug side effect: reckless behavior

     NY Post via Yahoo News· 7 days ago

     Ozempic, along with other semaglutide or tirzepatide drugs, has been associated with myriad side...

9. • Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against...

     Benzinga· 6 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Equinix EQIX, Harbor Diversified ...

10. • Surprise Discovery Reveals Ozempic Lowers Risk of Diabetic Kidney Disease

      ScienceAlert via Yahoo News· 3 days ago

      It's not yet understood why semaglutide and other GLP-1 agonists on the market, such as liraglutide and tirzepatide, have positive effects on cardiovascular and kidney health ...